- Research Article
- Open Access
Multi-locus variable-number tandem repeat analysis of Chinese Brucella strains isolated from 1953 to 2013
- Guo-Zhong Tian†1,
- Bu-Yun Cui†1,
- Dong-Ri Piao1,
- Hong-Yan Zhao1,
- Lan-Yu Li1,
- Xi Liu1,
- Pei Xiao2,
- Zhong-Zhi Zhao3,
- Li-Qing Xu3,
- Hai Jiang1Email author and
- Zhen-Jun Li1Email author
© The Author(s). 2017
- Received: 9 May 2016
- Accepted: 29 March 2017
- Published: 2 May 2017
Brucellosis was a common human and livestock disease caused by Brucella strains, the category B priority pathogens by the US Center for Disease Control (CDC). Identified as a priority disease in human and livestock populations, the increasing incidence in recent years in China needs urgent control measures for this disease but the molecular background important for monitoring the epidemiology of Brucella strains at the national level is still lacking.
A total of 600 Brucella isolates collected during 60 years (from 1953 to 2013) in China were genotyped by multiple locus variable-number tandem repeat analysis (MLVA) and the variation degree of MLVA11 loci was calculated by the Hunter Gaston Diversity Index (HGDI) values. The charts and map were processed by Excel 2013, and cluster analysis and epidemiological distribution was performed using BioNumerics (version 5.1).
The 600 representative Brucella isolates fell into 104 genotypes with 58 singleton genotypes by the MLVA11 assay, including B. melitensis biovars 2 and 3 (five main genotypes), B. abortus biovars 1 and 3 (two main genotypes), B. suis biovars 1 and 3 (three main genotypes), and B. canis (two main genotypes) respectively. While most B. suis biovar 1 and biovar 3 were respectively found in northern provinces and southern provinces, B. melitensis and B. abortus strains were dominant in China. Canine Brucellosis was only found in animals without any human cases reported. Eight Brucellosis epidemic peaks emerged during the 60 years between 1953 and 2013: 1955 – 1959, 1962 – 1969, 1971 – 1975, 1977 – 1983, 1985 – 1989, 1992 – 1997, 2000 – 2008 and 2010 – 2013 in China.
Brucellosis has its unique molecular epidemiological patterns with specific spatial and temporal distribution according to MLVA.
- Molecular epidemiology
Please see Additional file 1 for translation of the abstract into the five official working languages of the United Nations.
Brucellosis is one of the world’s most widespread zoonotic diseases. It is also seen as a reemerging infectious disease because of increasing incidence in recent years. It also is identified as a priority disease needing urgent control measures in human and livestock populations in China [1–7]. A total of 43 486 confirmed human cases were reported in 2013 (annual incidence of 3.3 cases/100 000 population) in China, and 57 222 cases were reported in 2014. Brucellosis has been found in all China.
Previous studies have confirmed that the multiple locus variable-number tandem repeat analysis (MLVA) is a useful tool for identifying and genotyping of strains and for epidemiological trace-back investigations . It was also applied in Brucella [5–7]. The objectives of this study was to analyze the genotyping of 600 Brucella isolates, which were isolated from 1953 to 2013 in China by multiple locus variable-number tandem repeat analysis (MLVA) in order to more comprehensively understand the patterns of molecular epidemiology of Brucellosis in China, to trace the flow direction and variation of Brucella, and to provide reference information for the prevention and control of Brucellosis in China.
Brucella isolates data
There were 2 620 human and animal field Brucella isolates, which were collected from 29 provinces in China from 1953 to 2013. These strains came from the provincial CDC which were isolated and cultured from blood and tissues (such as liver and spleen). These isolates were identified as Brucella based on distinct host specificity, pathogenicity, and minor phenotypic differences based on serotyping, phage typing, fuchsin and thionin dye sensitivity, CO2 requirement, H2S production and metabolic properties . They were dried and preserved in the −80 °C refrigerator in our laboratory. The stratified sampling method was used to select the number of Brucella isolates for this study. The definition of strata was Brucella bioytping. The selected proportion was 20.0% in each strata. 22.9% (600/2 620) of Brucella isolates were selected for this study.
Molecular typing methods
Total genomic DNA was individually extracted from the 600 representative strains and MLVA was performed as described previously [10, 11]. The MLVA11 assay involved 11 loci including Bruce06, Bruce08, Bruce11, Bruce12, Bruce18, Bruce19, Bruce21, Bruce42, Bruce43, Bruce45, and Bruce55. A total of 11 PCR primers were labeled with 5′-fluorescent 6-FAM and PCR products were resolved by capillary electrophoresis on an ABI Prism 3130 automated fluorescent capillary DNA sequencer (Applied Biosystems). The PCR fragment sizes were converted to repeat units by following the published allele numbering system (http://mlva.u-psud.fr, Brucella support website for MLVA typing). All data were analyzed by using BioNumerics (version 5.1, Applied Maths, Belgium). Cluster analysis was based on the categorical coefficient and unweighted pair group method using arithmetic averages (UPGMA) method. The variation degree of MLVA11 loci was calculated by Hunter Gaston Diversity Index (HGDI) values. The charts and map were produced by Excel 2013.
Genetic diversity of MLVA-11 loci and cluster analysis
HGDI values of MLVA-11 loci for Brucella strains
Diversity Index (n = 600)
0.843 – 0.892
0.713 – 0.802
0.646 – 0.760
0.548 – 0.692
0.465 – 0.669
0.441 – 0.624
0.424 – 0.603
0.424 – 0.600
0.406 – 0.601
0.290 – 0.501
0.271 – 0.458
Among the 104 genotypes were 12 main genotypes with more than two thirds 70.7% (424/600) of the 600 Brucella isolates. Specifically, 5 genotypes (M7, M9, M12, M13 and M14) accounted for 73.4% (292/398) of the B. melitensis strains. Two genotypes (A6 and A21) encompassed 59.8% (58/97) of B. abortus. Genotypes S1, S2, and S7 contained 62.1% (36/58) of the B. suis isolates whereas genotypes Ca2 and Ca3 covered 80.9% (38/47) of the B. canis strains (Fig. 2).
The 600 Brucella strains were respectively isolated from blue sheep and pig (one strain each), camel (two), deer (three), yak (four), goat (12), swine (19), dog (47), sheep (81), cattle (90), human (272) and unknown (68).
The time frame and geographic regions of the isolated strains
The four clusters (B1, B2, B3 and B4) consisted of 97 B. abortus isolates had a percentage of genetic similarity coefficient of 75.0%. The dominating cluster B1 included 81 B. abortus biovars 1 and 3 isolates from Inner Mongolia, Heilongjiang, Hebei, Xinjiang and Chongqing provinces during 1973 – 1979, 1984 – 1985 and 2010 – 2013. The three B. abortus biovar 3 isolates comprising cluster B2 were from Liaoning, Inner Mongolia and Beijing provinces during 1953 – 1956. By contrast of cluster B4 with just a single isolate from Anhui province in 2013, cluster B3 had 12 strains of B. abortus biovar 1 and 3 isolates from Xinjiang, Inner Mongolia, Tianjin, Sichuan, Anhui and Shanghai provinces during 1955 – 1964, 1980 – 1981 and 2013 (Fig. 5).
The D1, D3, D4 clusters (58 B. suis isolates) had a percentage of genetic similarity coefficient of 65.9%. Cluster D1 (28 biovar 3 B. suis strains) were isolated from Guangdong, Guangxi and Hainan provinces during 1962 – 1964, 1973 – 1979, 1986 – 1987 and 2010 – 2013. The second included 28 B. suis biovar 1 isolates, representing cluster D3, were from Inner Mongolia, Ningxia, Beijing, Jilin and Hunan provinces collected during 1957 – 1962, 1973 – 1979, 1986 – 1987, 2008 and 2013. D4 was a small cluster with only two biovar 2 isolates of B. suis from Gansu province in 2013 (Fig. 5).
With a percentage of genetic similarity coefficient of 84.1%, cluster D2 (47 B. canis isolates) was consisted of genotypes Ca2 and Ca3. Genotype Ca2 (31.9%, 15/47) were isolated from Zhejiang, Anhui and Jiangxi provinces during 1986 – 1988 and 2010 – 2011. Genotype Ca3 (48.9%, 23/47) were collected from Xinjiang, Inner Mongolia and Liaoning provinces during 1986 – 1989 (Fig. 5).
For many years, phenotypic characterization for Brucella strains was the only feasible way to provide epidemiological data with the disadvantage of lacking information related to their molecular background [8, 12]. Now with molecular tools, more options are available.
Although having higher discriminatory power than the MLVA11 assay, the MLVA16 assay with a set of 16 repeat loci is better for teasing out the difference of closely related isolates at fine-scale resolution whereas the MLVA11 assay is more suitable to analyze the phylogenetic and epidemiological relationships of Brucella strains because of its lesser degree of variation degree (HGDI values) [11, 13–18]. In accord with this notion, the genotyping results of MLVA11 assay have been consistent with those of MLVA71 assay genotyping , Brucella-specific IS711 element analysis , and whole-genome-based phylogeny studies [15, 16]. Therefore, we chose the MLVA11 assay to study the molecular epidemiology of Brucella isolates from China.
Considering the finding that most of the cluster A1 strains (93.5% of the B. melitensis biovars 2 and 3, with a percentage of genetic similarity coefficient of 62.4%) have been existing in different provinces for a long time (from 1953 to 2013) whereas clusters A2 and A3 isolates started to appear in 2013 in Inner Mongolia, Xinjiang and Shanxi provinces (Fig. 1), questions arise such as whether these cluster A2 and A3 strains are variants of other biovars, or have they been causing diseases all these years but without being isolated, what is its impact on trend of Brucellosis in China, and so on. All such questions remain to be answered in the future.
Taken together, our study showed the MLVA is a reliable monitoring method for the molecular epidemiology of Brucellosis relating to strain phylogeny and the regional and time distribution of the disease, potentially valuable for predicting the epidemic trend of Brucellosis in China.
This study was supported by grants from the Chinese National Programs for High Technology Research and Development: Lab Infectious Materials and Biological Risk Source Key Technology and Product Research (No. 2014AA021404) and the National Nature Science Foundation (No. 81271900). We would like to thank the staff who were involved and contributed to the data and Brucella isolate collection across the country. We are also grateful to all the staff of the Department of Brucellosis, National Institute for Communicable Disease Control and Prevention, Chinese Center Disease Control and Prevention for their contribution to this research. We are grateful to Professor Xin-He Lai, Department of Pediatrics & Insitute of Translational Medicine, Wenzhou Medical University, for proofreading the final version of the manuscript.
Availability of data and materials
Please contact the corresponding author for data requests.
GT, BC and ZL proposed the idea and designed the study. GT, DP, HZ, LL, XL, PX, ZZ and LX characterized the Brucella strains by classical biotyping methods. GT, BC, HJ, PX conducted the MLVA analysis. GT, BC, HJ and ZL performed the statistical analysis. All authors read and approved the final version of the submitted manuscript.
The authors declared that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
Ethical approval was received from National Institute for Communicable Disease Control and Prevention, Chinese Center Disease Control and Prevention. Ethical Committee Approval Notice ICDC-2015007.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human Brucellosis. Lancet Infect Dis. 2006;6:91–9.View ArticlePubMedGoogle Scholar
- Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010;140:392–8.View ArticlePubMedGoogle Scholar
- Deqiu S, Donglou X, Jiming Y. Epidemiology and control of Brucellosis in China. Vet Microbiol. 2002;90:165–82.View ArticlePubMedGoogle Scholar
- Zhang WY, Guo WD, Sun SH, Jiang JF, Sun HL, Li SL, et al. Human brucellosis, inner Mongolia. China Emerg Infect Dis. 2010;16:2001–3.View ArticlePubMedGoogle Scholar
- Jiang H, Wang H, Xu L, Hu G, Ma J, Xiao P, et al. MLVA genotyping of Brucella melitensis and Brucella abortus isolates from different animal species and human and identification of Brucella suis vaccine strain S2 from cattle in China. PLoS One. 2013;8:e76332.View ArticlePubMedPubMed CentralGoogle Scholar
- Li Z, Cui B, Chen H, Chen J, Zhao H, Piao D, et al. Molecular typing of Brucella suis collected from 1960s to 2010s in China by MLVA and PFGE. Biomed Environ Sci. 2013;26:504–8.PubMedGoogle Scholar
- Di D, Cui B, Wang H, Zhao H, Piao D, Tian L, et al. Genetic polymorphism characteristics of Brucella canis isolated in China. PLoS One. 2014;9:e84862.View ArticlePubMedPubMed CentralGoogle Scholar
- Al Dahouk S, Flèche PL, Nöckler K, Jacques I, Grayon M, Scholz HC, et al. Evaluation of Brucella MLVA typing for human Brucellosis. J Microbiol Methods. 2007;69:137–45.View ArticlePubMedGoogle Scholar
- Alton G, Jones L. Laboratory techniques in Brucellosis. Monogr Ser World Health Organ. 1967;55:1–92.PubMedGoogle Scholar
- Marianelli C, Graziani C, Santangelo C, Xibilia MT, Imbriani A, Amato R, et al. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from human in Sicily. Italy J Clin Microbiol. 2007;45:2923–8.View ArticlePubMedGoogle Scholar
- Maquart M, Le Flèche P, Foster G, Tryland M, Ramisse F, Djønne B, et al. MLVA-16 typing of 295 marine mammal Brucella isolates from different animal and geographic origins identifies 7 major groups within Brucella ceti and Brucella pinnipedialis. BMC Microbiol. 2009;9:145.View ArticlePubMedPubMed CentralGoogle Scholar
- Whatmore AM. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol. 2009;9:1168–84.View ArticlePubMedGoogle Scholar
- Audic S, Lescot M, Claverie JM, Cloeckaert A, Zygmunt MS. The genome sequence of Brucella pinnipedialis B2/94 sheds light on the evolutionary history of the genus Brucella. BMC Evol Biol. 2011;11:200.View ArticlePubMedPubMed CentralGoogle Scholar
- Chen Y, Zhen Q, Wang Y, Xu J, Sun Y, Li T, et al. Development of an extended multilocus sequence typing for genotyping of Brucella isolates. J Microbiol Methods. 2011;86:252–4.View ArticlePubMedGoogle Scholar
- Foster JT, Beckstrom-Sternberg SM, Pearson T, Beckstrom-Sternberg JS, Chain PS, Roberto FF, et al. Whole-genome-based phylogeny and divergence of the genus Brucella. J Bacteriol. 2009;191:2864–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Foster JT, Price LB, Beckstrom-Sternberg SM, Pearson T, Brown WD, Kiesling DM, et al. Genotyping of Brucella species using clade specific SNPs. BMC Microbiol. 2012;12:110.View ArticlePubMedPubMed CentralGoogle Scholar
- Garofolo G, Di Giannatale E, De Massis F, Zilli K, Ancora M, Cammà C, et al. Investigating genetic diversity of Brucella abortus and Brucella melitensis in Italy with MLVA-16. Infect Genet Evol. 2013;19:59–70.View ArticlePubMedGoogle Scholar
- Dorneles EM, Santana JA, Alves TM, Pauletti RB, Mol JP, Heinemann MB, et al. Genetic stability of Brucella abortus isolates from an outbreak by multiple-locus variable-number tandem repeat analysis (MLVA16). BMC Microbiol. 2014;14:186.View ArticlePubMedPubMed CentralGoogle Scholar
- Le Flèche P, Jacques I, Grayon M, Al Dahouk S, Bouchon P, Denoeud F, et al. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiol. 2006;6:9.View ArticlePubMedPubMed CentralGoogle Scholar